Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Maina

Showing results (31-40 of 257) with videos related to

Pageof 26
Sort By:
Depression and Anxiety|September 30, 2006
Axis I and II comorbidities in subjects with and without nocturnal panicUmberto Albert, Giuseppe Maina, Chiara Bergesio, et al.
The American Journal on Addictions|March 23, 2026
Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications-a systematic reviewValerio Ricci, Thomas Fraccalini, Giovanni Martinotti, et al.
Psychiatry Research|May 30, 2026
Functional recovery trajectories in cannabis-induced first-episode psychosis: The role of dissociative symptoms in the discrepancy between symptomatic improvement and functional outcomesValerio Ricci, Andrea Paggi, Giovanni Martinotti, et al.
Neuroscience and Biobehavioral Reviews|February 18, 2026
Biomarkers for Predicting Transition from At-Risk Mental State to Psychosis: A Systematic ReviewValerio Ricci, Giovanni Martinotti, Alessio Mosca, et al.
Healthcare (Basel, Switzerland)|December 30, 2025
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic EfficacyValerio Ricci, Stefania Chiappini, Giovanni Martinotti, et al.
Archives of Women'S Mental Health|January 23, 2014
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian womenGiuseppe Maina, Gianluca Rosso, Andrea Aguglia, et al.
The Journal of Clinical Psychiatry|February 26, 2008
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot studyGiuseppe Maina, Umberto Albert, Gianluca Rosso, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 19, 2008
8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderGiuseppe Maina, Enrico Pessina, Umberto Albert, et al.
Journal of Clinical Psychopharmacology|January 28, 2017
Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 CasesGianluca Rosso, Francesca Solia, Umberto Albert, et al.
International Clinical Psychopharmacology|July 25, 2009
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary studyEnrico Pessina, Umberto Albert, Filippo Bogetto, et al.
Pageof 26

Showing results (31-40 of 257) with videos related to

Sort By:
Pageof 26
Depression and Anxiety|September 30, 2006
Axis I and II comorbidities in subjects with and without nocturnal panicUmberto Albert, Giuseppe Maina, Chiara Bergesio, et al.
The American Journal on Addictions|March 23, 2026
Cannabis cessation and neurocognitive recovery: Patterns, predictors, and clinical implications-a systematic reviewValerio Ricci, Thomas Fraccalini, Giovanni Martinotti, et al.
Psychiatry Research|May 30, 2026
Functional recovery trajectories in cannabis-induced first-episode psychosis: The role of dissociative symptoms in the discrepancy between symptomatic improvement and functional outcomesValerio Ricci, Andrea Paggi, Giovanni Martinotti, et al.
Neuroscience and Biobehavioral Reviews|February 18, 2026
Biomarkers for Predicting Transition from At-Risk Mental State to Psychosis: A Systematic ReviewValerio Ricci, Giovanni Martinotti, Alessio Mosca, et al.
Healthcare (Basel, Switzerland)|December 30, 2025
Substance-Specific Treatment Responses and Resistance Patterns in Induced Psychoses: A Scoping Review of Antipsychotic EfficacyValerio Ricci, Stefania Chiappini, Giovanni Martinotti, et al.
Archives of Women'S Mental Health|January 23, 2014
Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian womenGiuseppe Maina, Gianluca Rosso, Andrea Aguglia, et al.
The Journal of Clinical Psychiatry|February 26, 2008
Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot studyGiuseppe Maina, Umberto Albert, Gianluca Rosso, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 19, 2008
8-week, single-blind, randomized trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorderGiuseppe Maina, Enrico Pessina, Umberto Albert, et al.
Journal of Clinical Psychopharmacology|January 28, 2017
Affective Recurrences in Bipolar Disorder After Switching From Lithium to Valproate or Vice Versa: A Series of 57 CasesGianluca Rosso, Francesca Solia, Umberto Albert, et al.
International Clinical Psychopharmacology|July 25, 2009
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary studyEnrico Pessina, Umberto Albert, Filippo Bogetto, et al.
Pageof 26